COVID‐19 pandemic and mental distress in multiple sclerosis: Implications for clinical management
2020 · European Journal of Neurology · 64 citations
https://doi.org/10.1111/ene.14580
M
Maria Cellerino
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
90
Papers
1.2K
Citations
19
h-index
35
i10-index
Maria Cellerino is an academic researcher from Ospedale Policlinico San Martino. The author has contributed to research in topics: Multiple Sclerosis Research Studies & Peripheral Neuropathies and Disorders & Systemic Lupus Erythematosus Research. The author has an h-index of 19, co-authored 77 publications.
ORCID: 0000-0002-4359-9872Papers by this author
worksPredictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
2021 · Neurotherapeutics · 38 citations
https://doi.org/10.1007/s13311-021-01104-8
Predicting disease severity in multiple sclerosis using multimodal data and machine learning
2023 · Journal of Neurology · 29 citations
https://doi.org/10.1007/s00415-023-12132-z
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study
2024 · Journal of Neurology · 15 citations
https://doi.org/10.1007/s00415-024-12360-x
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients
2023 · Journal of Neurology · 10 citations
https://doi.org/10.1007/s00415-023-12084-4
The role of disconnection in explaining disability in multiple sclerosis
2022 · European Radiology Experimental · 9 citations
https://doi.org/10.1186/s41747-022-00277-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat